NGNE
Neurogene Inc
NASDAQ: NGNE · HEALTHCARE · BIOTECHNOLOGY
$26.48
-3.53% today
Updated 2026-04-29
Market cap
$422.41M
P/E ratio
—
P/S ratio
438.73x
EPS (TTM)
$-4.24
Dividend yield
—
52W range
$12 – $37
Volume
0.2M
Neurogene Inc (NGNE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $25.00M | — | — | $0.00 | $0.00 | $0.00 | $925000.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | -100.0% | — | — | — | — | — | -100.0% |
| Cost of revenue | $125597.00 | $130784.00 | $59571.00 | $135946.00 | — | — | — | — | $340000.00 | $1.82M | $42.26M | $3.20M | $3.26M | $3.25M | $3.19M |
| Gross profit | $-125597.00 | $-130784.00 | $-59571.00 | $-135946.00 | — | — | — | $25.00M | $-340000.00 | $-1.82M | $-42.26M | $-3.20M | $-3.26M | $-2.32M | $-3.19M |
| Gross margin | — | — | — | — | — | — | — | 100.0% | — | — | — | — | — | -251.0% | — |
| R&D | $8.58M | $5.91M | $7.54M | $17.94M | $15.80M | $28.38M | $36.27M | $32.79M | $6.32M | $24.34M | $42.26M | $47.51M | $44.39M | $60.92M | $75.01M |
| SG&A | — | — | — | — | — | — | — | — | — | — | $8.27M | $9.01M | $11.19M | $22.61M | $28.32M |
| Operating income | $-10.43M | $-7.68M | $-9.38M | $-22.38M | $-21.34M | $-37.65M | $-51.12M | $-23.52M | $-24.44M | $-41.55M | $-50.53M | $-56.52M | $-55.58M | $-82.61M | $-103.21M |
| Operating margin | — | — | — | — | — | — | — | -94.1% | — | — | — | — | — | -8930.3% | — |
| EBITDA | $-10.54M | $-7.54M | $-8.63M | $-21.65M | $-21.76M | $-37.00M | $-50.18M | $-31.58M | $-69.10M | $-31.46M | $-49.59M | $-51.99M | $-52.29M | $-71.89M | $-103.33M |
| EBITDA margin | — | — | — | — | — | — | — | -126.3% | — | — | — | — | — | -7771.4% | — |
| EBIT | $-10.66M | $-7.67M | $-8.69M | $-21.78M | $-21.34M | $-37.00M | $-50.18M | — | $-69.44M | $-33.28M | $-50.53M | $-55.19M | $-55.58M | $-75.13M | — |
| Interest expense | — | — | $42923.00 | $2.25M | $99000.00 | $1000.00 | $4000.00 | $4000.00 | $1000.00 | — | $0.00 | $2000.00 | $12000.00 | $12000.00 | $5000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-10.51M | $-7.71M | $-8.73M | $-23.82M | $-21.86M | $-37.00M | $-50.18M | $-31.59M | $-69.44M | $-33.28M | $-50.52M | $-55.19M | $-36.32M | $-75.14M | $-90.35M |
| Net income growth (YoY) | — | +26.6% | -13.2% | -172.9% | +8.2% | -69.3% | -35.6% | +37.1% | -119.9% | +52.1% | -51.8% | -9.2% | +34.2% | -106.9% | -20.2% |
| Profit margin | — | — | — | — | — | — | — | -126.3% | — | — | — | — | — | -8123.7% | — |